Back to all Programs

Register here

Related Materials

Past event

European Workshop on NASH in Clinical Practice 2019

Viral Hepatitis and Liver Disease

Natural History of NASH Emmanuel Tsochatzis, MD, MSc, FEBTM, FRCP, PhD

Viral Hepatitis and Liver Disease

NASH Epidemiology and Policy Jeffrey Lazarus, PhD, MIH, MA

Viral Hepatitis and Liver Disease

NASH Diagnostics and Management in General Medicine - Rachel Pryke, MBBS, MRCGP, FRCP

Viral Hepatitis and Liver Disease

Obesity Management - Jude Oben, MD, PhD

Viral Hepatitis and Liver Disease

Diabetes Management - Beatriz Gonzalez, MD

Viral Hepatitis and Liver Disease

Management of Lean NASH - Ramy Younes, MD

Viral Hepatitis and Liver Disease

Pediatric NAFLD - Alastair Baker, MB, ChB, FRCP, FRCPCH, MBA

Viral Hepatitis and Liver Disease

NASH in HIV - Berend van Welzen, MD

Viral Hepatitis and Liver Disease

New Biomarkers in NAFLD - Manuel Romero-Gomez, MD

Viral Hepatitis and Liver Disease

How to Implement a Healthy Lifestyle in NAFLD/NASH Patients - Shira Zelber Sagi, PhD

Viral Hepatitis and Liver Disease

Drug-Induced Liver Injury and NASH - Raul Andrade, MD, PhD

Viral Hepatitis and Liver Disease

Cardiovascular Risk in NAFLD - Jorn M. Schattenberg, MD

Viral Hepatitis and Liver Disease

NASH and Immune-Mediated Diseases - Maria Teresa Arias Loste, MD, PhD

Viral Hepatitis and Liver Disease

Future Treatment and Management Options - Vlad Ratziu, MD, PhD

Viral Hepatitis and Liver Disease

Patient Perspective - Teresa Casanovas, MD and Maite Pujol

Viral Hepatitis and Liver Disease

NASH/NAFLD as Cause for HCC - Helen Reeves, MD, PhD